Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on this website, type “NCT02419612” into
the search box and click “Search”
• www.clinicaltrialsregister.eu Once you are on the website, click “Home and
Search”, then type “2014-003721-18” in the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D1689C00013” into the search box, and click “Find a Study”.
Full Trial Title: A 52-week International, Multicenter, Randomized, Double-
Blind, Active-Controlled, Parallel Group, Phase 3b Trial with a Blinded 104-week
Long-term Extension Period to Evaluate the Efficacy and Safety of Saxagliptin
Co-administered with Dapagliflozin in Combination with Metformin Compared to
Glimepiride in Combination with Metformin in Adult Patients with Type 2 Diabetes
Who Have Inadequate Glycemic Control on Metformin Therapy Alone
National Clinical Trials number: NCT02419612
AstraZeneca Protocol Number: D1689C00013
AstraZeneca sponsored this study and has its headquarters in Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
TThe Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 2.0 2020_08_03 12